Arterial Bypass Grafting for Critical Limb Ischemia

Clinical Justification for Intervention

• The American Heart Association recommends revascularization as the primary approach for critical limb ischemia (CLI) patients, unless survival is very limited, independent ambulation is unlikely, or the general medical condition is poor 1
• The American College of Cardiology states that the absence of wounds is favorable for revascularization, as it indicates no significant necrosis of weight-bearing foot portions 2, 1
• Major amputation carries a 4-30% 30-day mortality and 20-37% morbidity risk, making revascularization strongly preferred 1

Anatomic Pattern Requiring Surgical Intervention

• The Society for Vascular Surgery recommends aortobifemoral bypass for patients with symptomatic, hemodynamically significant aorto-bi-iliac disease requiring intervention (Class I, Level of Evidence A) 3, 1, 4
• Aortobifemoral bypass achieves excellent outcomes, with 87.5% limb-based 5-year patency and 80.4% patient-based 5-year patency 3, 4

Surgical Approach Selection

• The American Heart Association recommends addressing inflow lesions first in patients with combined inflow and outflow disease with CLI (Class I, Level of Evidence B) 2, 3, 1
• If CLI symptoms or infection persist after inflow revascularization, an outflow revascularization procedure should be performed (Class I, Level of Evidence B) 2, 1

Critical Caveat: Renal Artery Involvement

• The American College of Cardiology states that simultaneous aortorenal bypass or alternative renal revascularization may be required to preserve renal function if the renal artery is occluded 5, 6
• Preoperative assessment of renal function and consideration of nephrology consultation is essential 5, 6

Alternative Approaches if Patient is High-Risk

• The Society for Vascular Surgery recommends axillofemoral-femoral bypass for CLI patients with extensive aortoiliac disease who are not candidates for other interventions (Class I, Level of Evidence B) 2, 1, 4

Superiority Over Amputation

• The American Heart Association states that distal arterial reconstruction has a lower mortality rate (0-6%) compared to major amputation (4-30%) 1
• Major amputation has a significant impact on independence, with rehabilitation difficulties and inability to ambulate with prosthesis in older patients 1

Aortofemoral Bypass Mortality

Mortality Data from High-Quality Evidence

• The American College of Cardiology/American Heart Association guidelines establish the benchmark mortality rate for aortobifemoral bypass at 3.3% with an associated morbidity of 8.3% in a population of over 8,000 procedures 7

Major Causes of Perioperative Mortality and Morbidity

• Myocardial infarction occurs in 0.8% to 5.2% of aortobifemoral bypass cases, contributing to operative mortality and serious morbidity 7
• Renal failure occurs in 0% to 4.6% of aortobifemoral bypass cases, contributing to operative mortality and serious morbidity 7

Comparison with Alternative Procedures

• Femorofemoral bypass has an operative mortality of 6% 8
• Axillofemoral bypass has an operative mortality of 6% 8
• Axillofemoral-femoral bypass has an operative mortality of 4.9% 8

Clinical Context for Decision-Making

• For patients with lifestyle-limiting claudication or critical limb ischemia who are acceptable surgical candidates, aortobifemoral bypass remains the gold standard intervention, offering excellent long-term patency with acceptable mortality risk, according to the American College of Cardiology/American Heart Association guidelines 7, 8
• The presence of comorbid cardiovascular disease substantially influences both operative risk and long-term outcomes, and patients deemed high cardiovascular or surgical risk should be considered for alternative procedures such as axillofemoral-femoral bypass 7

Femoral‑Popliteal Bypass: Evidence‑Based Recommendations

Conduit Selection

• The American College of Cardiology recommends autogenous saphenous vein as the mandatory first‑line conduit for femoral‑popliteal bypass because it provides superior long‑term patency and reduces the need for re‑intervention. [9][10]11
• Autogenous saphenous vein grafts achieve approximately 70 % primary patency at 5 years and should be employed whenever feasible, using either in‑situ or reversed configurations. [10][12]
• Prosthetic grafts (PTFE or Dacron) to the popliteal artery have significantly lower patency rates and higher repeat‑intervention rates compared with autogenous vein grafts. [9][10]
• Below‑knee prosthetic grafts are advised against because they exhibit accelerated failure, especially when tibial runoff is poor. 12

Preoperative Assessment

• The American College of Cardiology advises routine bilateral lower‑extremity arterial imaging to identify combined inflow (iliac) and outflow (femoral‑popliteal) disease before bypass planning. 13

Anesthesia

• Both general anesthesia and regional anesthesia are acceptable options for femoral‑popliteal bypass procedures. [9][13]

Surgical Technique – Anastomotic Site

• The location of the popliteal anastomosis (above‑knee versus below‑knee) is a major determinant of graft outcomes; for prosthetic conduits, an above‑knee anastomosis is generally preferred. [9][11]

Indications & Contraindications

• The American College of Cardiology states that femoral‑tibial bypass using prosthetic material should not be performed for claudication because outcomes are unacceptably poor. 10
• Revascularization should not be undertaken solely to prevent progression from claudication to critical limb ischemia, as procedural risks outweigh theoretical benefits. [10][13]